Research Letter: PDF OnlyEndometrial Cancer Detection During the Coronavirus Disease 2019 (COVID-19) PandemicSuh-Burgmann, Elizabeth J. MD; Alavi, Mubarika MS; Schmittdiel, Julie PhDAuthor Information Division of Gynecologic Oncology, The Permanente Medical Group, Walnut Creek, and the Division of Research, Kaiser Permanente Northern California, Oakland, California. Corresponding author: Elizabeth J. Suh-Burgmann, MD, Division of Gynecologic Oncology, The Permanente Medical Group, Division of Research, Kaiser Permanente Northern California, Walnut Creek, CA; email: Betty.Suh-Burgmann@kp.org. Financial Disclosure The authors did not report any potential conflicts of interest. The study was funded by The Permanente Medical Group Physician Researcher Program. Each author has confirmed compliance with the journal's requirements for authorship. Peer reviews and author correspondence are available at http://links.lww.com/AOG/C21. Received June 10, 2020 Received in revised form July 05, 2020 Accepted July 9, 2020 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. Obstetrics & Gynecology: July 21, 2020 - Volume Publish Ahead of Print - Issue - doi: 10.1097/AOG.0000000000004087 Open PAP Metrics During the first 12 weeks of the coronavirus disease 2019 (COVID-19) pandemic, endometrial cancer diagnoses declined 35% and patient calls for abnormal bleeding declined 33% compared with 2019 levels. © 2020 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.